| Bioactivity | (S,R,S)-AHPC-Me-C6-NH2 can be used for the synthesis of PROTAC[1]. (S,R,S)-AHPC-Me-C6-NH2 (Compound SI-9) contains VHL ligand 2 (HY-112078)[2]. |
| Name | (S,R,S)-AHPC-Me-C6-NH2 |
| CAS | 2411422-49-4 |
| Formula | C30H45N5O4S |
| Molar Mass | 571.77 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | -20°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
| Reference | [1]. Haibing Zhou, et al. Oseltamivir PROTAC compound, preparation method thereof and application thereof in anti-influenza virus drugs. Patent CN112592331A. [2]. Bondeson DP, et al. Systematic profiling of conditional degron tag technologies for target validation studies. Nat Commun. 2022 Sep 20;13(1):5495. |
(S,R,S)-AHPC-Me-C6-NH2
CAS: 2411422-49-4 F: C30H45N5O4S W: 571.77
(S,R,S)-AHPC-Me-C6-NH2 can be used for the synthesis of PROTAC. (S,R,S)-AHPC-Me-C6-NH2 (Compound SI-9) contains VHL liga
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.